ALX Oncology Holdings Inc
(NAS:ALXO)
$
1.62
-0.07 (-4.14%)
Market Cap: 85.44 Mil
Enterprise Value: -49.60 Mil
PE Ratio: 0
PB Ratio: 0.63
GF Score: 27/100 ALX Oncology Holdings Inc at Jefferies Virtual London Healthcare Conference Transcript
Nov 19, 2020 / 06:10PM GMT
Release Date Price:
$70.64
(+9.52%)
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst
Hello, everybody. Welcome to another great session at the Jefferies Virtual London Global Healthcare Conference. I'm here with ALX Oncology. With us today, we have the CEO, Jaume Pons, with us here. We also have the Chief Medical Officer, Sophia Randolph. It's great to have you guys with us.
Jaume Pons
ALX Oncology Holdings Inc. - President, CEO & Director
Hello. Hi.
Sophia Randolph
ALX Oncology Holdings Inc. - Chief Medical Officer
Thank you.
Questions & Answers
Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst
Before we get into all the excellent data that was just presented at SITC, we won't do that just yet. I just wanted to maybe turn it over to you guys and ask you a broad question. The CD47 space, which you guys are involved in, has gotten a lot of attention recently. And there's been a lot of deals in that space. And I think people are starting to catch
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot